Opinion

Podcast

Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Author(s):

Lauren Miller, MPAS, PA-C,Jayme M Heim, MSN, FNP-BC

Lauren Miller, MPAS, PA-C; Jayme M. Heim, MSN FNP-BC, and Kirk Gautier, PA-C, discuss recent advancements in plaque psoriasis treatment, focusing on novel oral systemic therapies like the TYK-2 inhibitor deucravacitinib and its clinical trial data, to inform therapeutic decisions for this systemic disease.

Related Videos
Jennifer Flemming, MD | Credit: AASLD
3 experts are featured in this series.
John Kane, MD | Credit: Northwell Health
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Related Content
Reynold Panettieri, MD, vice chancellor for Translational Medicine and Science at Rutgers University,
January 16th 2025

Elevated Serum cAMP Findings May Allow Asthma Diagnosis by Blood Test

Victoria Johnson
Skin of Color Savvy: News Update—SOCS Awards, My Best Winter Skin, & TORPEDO Program
January 15th 2025

Skin of Color Savvy: News Update—SOCS Awards, My Best Winter Skin, & TORPEDO Program

Robert Brodell, MD
New Dosing Option for Bimekizumab Now Commercially Available for PsA, Psoriasis, HS
January 16th 2025

New Dosing Option for Bimekizumab Now Commercially Available for PsA, Psoriasis, HS

Tim Smith
Diabetes Dialogue: The Role of Dietitians in GLP-1 RA Use | Image Credit: HCPLive
January 13th 2025

Diabetes Dialogue: The Evolving Role of Registered Dietitian Nutritionists in Obesity

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Credit: Adobe Stock/ photobyphotoboy
January 16th 2025

Study Reveals Causal Link Between Apolipoprotein A-I, COPD

Chelsie Derman
Donghee Kim, MD, PhD | Credit: Stanford Medicine
January 16th 2025

Lean Steatotic Liver Disease Affects 12% of US Adults, Study Finds

Abigail Brooks, MA
© 2025 MJH Life Sciences

All rights reserved.